UBS has lowered the target price for Novonesis A/S to DKK 455, maintaining a neutral stance on the company. As a leading producer of enzymes and micro-organisms, Novonesis generates sales primarily from the cleaning and household products industry (28.5%) and bioenergy (24.8%), with significant contributions from food and human health (22.1%) and agriculture (11.8%). Geographically, North America accounts for 33.9% of sales, followed by Europe-Middle East-Africa (33.5%) and Asia-Pacific (18.5%).